HBK Investments’s Terns Pharmaceuticals TERN Stock Holding History

HBK Investments’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,950,000	Closed	-$156M	–	377
2026 Q1	$156M	Buy	+2,950,000	New	+$121M	1.58%	18

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HBK Investments's TERN Position: Q2 2026 in Review

HBK Investments sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 2,950,000 shares — an estimated $156M sold.

HBK Investments first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $156M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

HBK Investments reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
HBK Investments sold 2,950,000 Terns Pharmaceuticals shares in Q2 2026, an estimated $156M.
HBK Investments first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
HBK Investments's Terns Pharmaceuticals position peaked at $156M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on HBK Investments's 13F filing for Q2 2026, filed 14 Aug 2026.